International Journal of Radiation OncologyBiologyPhysics (INT J RADIAT ONCOL)

Publications in this journal

• Article: In Regard to Jakobsen et al

  Zsolt Fekete
  International Journal of Radiation OncologyBiologyPhysics 06/2013; 86(2):212-213.
• Article: The poor prognosis associated with a HPVα7 genotype in cervical carcinoma cannot be explained by intrinsic radiosensitivity

  Hall JS, Iype R, Armenoult LSC, Taylor J, Miller CJ, Davidson S, Bosch X, Stern P, West CML
  International Journal of Radiation OncologyBiologyPhysics 01/2013;
• Article: Effects of Tumor Tracking Errors to the Quality of Radiation Treatment

  I Buzurovic, TK Podder, Y Yu
  International Journal of Radiation OncologyBiologyPhysics 11/2012;
• Article: Management of Pediatric Myxopapillary Ependymoma: The Role of Adjuvant Radiation

  Agbahiwe, H. C, Wharam, Batra, Cohen, Terezakis
  International Journal of Radiation OncologyBiologyPhysics 07/2012;
• Article: Patterns of Practice in Palliative Radiotherapy for Painful Bone Metastases: A Survey in Japan.

  Naoki Nakamura, Naoto Shikama, Hitoshi Wada, Hideyuki Harada, Miwako Nozaki, Hisayasu Nagakura, Masao Tago, Masahiko Oguchi, Nobue Uchida, Japanese Radiation Oncology Study Group Working Subgroup of Palliative Radiotherapy
  [show abstract] [hide abstract]
  ABSTRACT: Purpose To determine the current patterns of practice in Japan and to investigate factors that may make clinicians reluctant to use single-fraction radiotherapy (SF-RT). Methods and Materials Members of the Japanese Radiation Oncology Study Group (JROSG) completed an Internet-based survey and described the radiotherapy dose fractionation they would recommend for four hypothetical cases describing patients with painful bone metastasis (BM). Case 1 described a patient with an uncomplicated painful BM in a non-weight-bearing site from non-small-cell lung cancer. Case 2 investigated whether management for a case of uncomplicated spinal BM would be different from that in Case 1. Case 3 was identical with Case 2 except for the presence of neuropathic pain. Case 4 investigated the prescription for an uncomplicated painful BM secondary to oligometastatic breast cancer. Radiation oncologists who recommended multifraction radiotherapy (MF-RT) for Case 2 were asked to explain why they considered MF-RT superior to SF-RT. Results A total of 52 radiation oncologists from 50 institutions (36% of JROSG institutions) responded. In all four cases, the most commonly prescribed regimen was 30 Gy in 10 fractions. SF-RT was recommended by 13% of respondents for Case 1, 6% for Case 2, 0% for Case 3, and 2% for Case 4. For Case 4, 29% of respondents prescribed a high-dose MF-RT regimen (e.g., 50 Gy in 25 fractions). The following factors were most often cited as reasons for preferring MF-RT: “time until first increase in pain” (85%), “incidence of spinal cord compression” (50%), and “incidence of pathologic fractures” (29%). Conclusions Japanese radiation oncologists prefer a schedule of 30 Gy in 10 fractions and are less likely to recommend SF-RT. Most Japanese radiation oncologists regard MF-RT as superior to SF-RT, based primarily on the time until first increase in pain.
  International Journal of Radiation OncologyBiologyPhysics 02/2012;
• Article: Exposure to ionizing radiation causes long-term increase in serum estradiol and activation of PI3K-Akt signaling pathway in mouse mammary gland

  Shubhankar Suman, Michael D. Johnson, Albert J. Fornace, Kamal Datta
  International Journal of Radiation OncologyBiologyPhysics 01/2012;
• Article: The Weakest Link-Medical Physicists Need Dedicated Software And Further Training To Improve The Quality Of Rotational IMRT

  O. De Hertogh, T. J. Bichay, R. Viard, B. Germain, Y. Boukour
  International Journal of Radiation OncologyBiologyPhysics 01/2012; 84(3):S130-131.
• Article: 2. Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy? Quan EM, Chang JY, Liao Z, Xia T, Yuan Z, Liu H, Li X, Wages CA, Mohan R, Zhang X. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):e69-76

  Quan EM, Chang JY, Liao Z, Xia T, Yuan Z, Liu H, Li X, Wages CA, Mohan R, Zhang X
  International Journal of Radiation OncologyBiologyPhysics 01/2012;
• Article: 4. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY. Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1017-23

  Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY
  International Journal of Radiation OncologyBiologyPhysics 01/2012;
• Article: L-boronophenylalanine-mediated boron neutron capture therapy for glioblastoma or anaplastic astrocy-toma progressing after external beam radiation therapy : A Phase I study

  Leena Kankaanranta, Tiina Seppala, Petteri Valimaki, Annette Beule, Juhani Collan, Mika Kortesniemi, Jouni Uusi-Simola, Petri Kotiluoto, Iiro Auterinen, Tom Seren, Anders Paetau, Kauko Saarilahti, Sauli Savolainen, Heikki Joensuu, Hanna Koivunoro
  International Journal of Radiation OncologyBiologyPhysics 01/2011; 80(2):369-376.
• Article: Bath and shower effects in the parotid gland explain increased relative risk of parotid gland dysfunction after IMRT

  Peter van Luijk, Hette Faber, Jacobus M. Schippers, Sytze Brandenburg, Johannes A. Langendijk, Harm Meertens, Robert P. Coppes
  International Journal of Radiation OncologyBiologyPhysics 01/2009; 74:1002.
• Article: 2. Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats. Liu H, Xiong M, Xia YF, Cui NJ, Lu RB, Deng L, Lin YH, Rong TH. Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1552-9

  Liu H, Xiong M, Xia YF, Cui NJ, Lu RB, Deng L, Lin YH, Rong TH
  International Journal of Radiation OncologyBiologyPhysics 01/2009;
• Article: Elective Nodal Irradiation (ENI) doesn't appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC).

  Steven E Schild
  International Journal of Radiation OncologyBiologyPhysics 11/2008; 72(2):311-2.
• Article: Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC).

  José S A Belderbos, Lucyna Kepka, Feng-Ming Spring Kong, Mary K Martel, Gregory M M Videtic, Branislav Jeremic
  [show abstract] [hide abstract]
  ABSTRACT: Lymphatic spread is an important pathway of progression in non-small-cell lung cancer (NSCLC), along with local spread and distant metastasis. The probability of lymph node (LN) involvement is dependent on the site of the primary tumor, stage, and histology. Elective nodal irradiation (ENI) is the irradiation of clinical and radiological uninvolved LN to account for microscopic tumor invasion in these LNs because we have not been able to determine the extent of LN spread accurately. The clinical value of ENI is uncertain. The impact of ENI is dependent on many (staging-, treatment-, and patient-related) factors. The purpose of this report is to analyze the current status of ENI and to provide comprehensive in-depth analysis and guidance on how to generally approach this issue in NSCLC.
  International Journal of Radiation OncologyBiologyPhysics 11/2008; 72(2):335-42.
• Article: Mental dysfunction after brain irradiation.

  John Healy
  International Journal of Radiation OncologyBiologyPhysics 11/2008; 72(2):628; author reply 628-30.